Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Zelira Therapeutics.
RELATED STOCKHEAD STORIES
Health & Biotech
ASX Health Stocks: Here’s a highlight from today’s half-year result announcements
Health & Biotech
Weed Week: Cannabis compounds could prevent Covid and Quebec’s no-jab, no-weed rule quadruples vaccinations
Health & Biotech
ASX Health Stocks: Immuron up 29pc on $6.2m travellers’ diarrhoea clinical study for US military
Health & Biotech
ASX Health Stocks: CSL drags Healthcare index down 5pc on a mammoth $6.3bn cap raise
News
Market Highlights and 5 ASX Small Caps to watch on Thursday
Health & Biotech
ASX Health Stocks: Paradigm rockets 21pc after getting FDA nod, Memphasys up 31pc on imminent launch
News
Market Highlights and 5 ASX Small Caps to watch on Wednesday
Health & Biotech
Check Up: Rhythm plans TGA submission and pig tissue MOU fails to impress
News
ASX Capital Raise Roundup: Low expectations + strong earnings =
Health & Biotech
Weed Week: Amazon scraps marijuana drug tests and Victorian council considers cannabis crops
Health & Biotech
ASX Health Stocks: AnteoTech initiates TGA submission, Zelira jumps 10pc after launching CBD-based acne gel
News
Market Highlights and 5 ASX Small Caps to watch on Thursday
Health & Biotech
ASX Health Stocks: Zelira shares jump on $4m cannabis distribution deal to Germany
News
Market Highlights and 5 ASX Small Caps to watch on Monday
News
Market highlights and 5 ASX small caps to watch on Monday
Health & Biotech
Weed Week: Connecticut and Mexico on board cannabis bandwagon, as Rinehart enters the industry
Health & Biotech